伊达鲁珠单抗
达比加群
医学
抗凝血酶
重症监护医学
心房颤动
外科
内科学
华法林
肝素
抗凝血酶
作者
Charles V. Pollack,Paul Reilly,John W. Eikelboom,Stephan Glund,Peter Verhamme,Richard A. Bernstein,Robert Dubiel,Menno V. Huisman,Elaine M. Hylek,Pieter W. Kamphuisen,Jörg Kreuzer,Jerrold H. Levy,Frank W. Sellke,Joachim Stangier,Thorsten Steiner,Bushi Wang,CW Kam,Jeffrey I. Weitz
标识
DOI:10.1056/nejmoa1502000
摘要
Specific reversal agents for non–vitamin K antagonist oral anticoagulants are lacking. Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran.
科研通智能强力驱动
Strongly Powered by AbleSci AI